There’s a lot of hope pinned to
vaccines, but it’s important that people understand that even if a vaccine is
authorized soon, we won’t fully feel the effects of it until next year. It will
take time to vaccinate the initial groups of people and frontline workers with
the required two doses that many of the early vaccine candidates require,
according to former US Food and Drug Administration Commissioner Dr. Scott
Gottlieb.
“The
vaccine is not going to affect the contours of what we’re going to go through
in the next two or three months,” he said.
So even
if we have a vaccine, we won’t be able to let up on masking and physical
distancing in the near future.
What’s
also important to note is that we won’t know from the vaccine trials if these
vaccines will actually save lives. Rather, the ongoing trials
are only designed to show if the vaccines prevent infection – and
most infections are mild, said Peter Doshi, a drug development specialist at
the University of Maryland.
"None of the
trials currently under way are designed to detect a reduction in any serious
outcome such as hospital admissions, use of intensive care, or deaths. Nor are
the vaccines being studied to determine whether they can interrupt transmission
of the virus," Doshi wrote in the the medical journal BMJ.
Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious
Diseases, said this week, “The primary thing you want to do is that if people
get infected, prevent them from getting sick, and if you prevent them from
getting sick, you will ultimately prevent them from getting seriously ill.”
Fauci agreed that a vaccine which prevents infection would be even better.
“If the vaccine also allows you to prevent initial infection, that would be
great,” he said, “But what I would settle for – and all of my colleagues would
settle for – is the primary endpoint to prevent clinically recognizable
disease.”
No comments:
Post a Comment